Mr. Damien McCallion:

I was describing the uptake. We have accounted for the specific groups and the necessary percentage uptake. Regarding the challenges on the procurement side, I am articulating what we have seen in the market. I can provide the Deputy with a note summarising the distinction between the public health guidance on the vaccine, which we articulated earlier, and the availability of the vaccine in the marketplace.